Recent Updates

Share
Twitter Facebook LinkedIn Forward
Published: 
Jan 15, 2021

Blood Components

Chapter 2

Whole blood donations are separated into specific cellular (red blood cells and platelets) and plasma components. Transfusing the appropriate blood component to effectively provide for the clinical needs of patients optimizes use of donated blood.

This chapter describes the manufacturing process for the most commonly prepared blood components:

  • Red blood cells (RBC)
  • Platelets: pooled and apheresis
  • Frozen plasma (FP)
  • Apheresis fresh frozen plasma (AFFP)
  • Cryosupernatant plasma (CSP)
  • Cryoprecipitate
Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Oct 6, 2020

Blood Administration

Chapter 9

This chapter focuses on the principles of safe blood transfusion practices. The aim of this chapter is to develop and support the knowledge of health-care professionals involved in prescribing and administering blood components and products.

Transfusion
Modified on: 
Jan 4, 2021
Share
Twitter Facebook LinkedIn Forward

COVID-19 and transfusion medicine

http://cancovid19plasma.ca/This repository aims to support Canadian transfusion medicine health care professionals during the COVID-19 pandemic. It will be updated regularly as new information is available. In addition, the public and donors can learn more about how Canadian Blood Services is responding to COVID-19 by visiting blood.ca/covid-19.

Transfusion
more

Upcoming Events

Topic Teaching: Platelet Transfusions in Neonates: What are the implications of recent research?

Share
Twitter Facebook LinkedIn Forward
When
January 19, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Professor Simon J Stanworth
Consultant Haematologist
NHS Blood and Transplant / Oxford University Hospitals NHS Foundation Trust

Objectives:

1.    Describe the results of a recent randomised trial of platelets in neonates.
2.    Recognise some of the strengths and limitations of the trial.
3.    Discuss the broader implications, including use of tranexamic acid as an alternative.

References:

n/a

 

Transfusion

U of T Rounds: SCD: Genotyping/alloimmunization prevention and management

Share
Twitter Facebook LinkedIn Forward
When
January 28, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion

Topic Teaching: Thrombocytopenic Disorders

Share
Twitter Facebook LinkedIn Forward
When
February 2, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion
more

Blog

Modified on: 
Jan 13, 2021
Share
Twitter Facebook LinkedIn Forward

Dr. Celina Montemayor-Garcia on the potential of genomics to shape the future of transfusion medicine

Dr. Celina Montemayor-Garcia is a researcher and transfusion medicine specialist whose main interest is understanding how genomics and bioinformatics can be used to improve care for transfusion patients. She spoke to us about advances in precision medicine and genomics, and what they could mean for the future of blood systems.

Transfusion

Modified on: 
Jan 11, 2021
Share
Twitter Facebook LinkedIn Forward

Breaking barriers to effective treatment for Alzheimer’s disease

Blood plasma-derived IVIg holds promise as a treatment for Alzheimer’s disease. A new study suggests that combining IVIg with a new drug delivery technique that helps get IVIg into the brain could increase its effectiveness and help make the best use of this precious treatment.

Transfusion

Modified on: 
Dec 30, 2020
Share
Twitter Facebook LinkedIn Forward

Top 5 blog posts of 2020

What a year 2020 has been! Take a look back with us by checking out the five most visited R.E.D. blog posts in 2020.

Transfusion

more